Xeris Biopharma Reaffirms 2021 Guidance and Provides Business Update

Go back to  Xeris Biopharma Reaffirms 2021 Guidance and Provides Business Update
(NASDAQ: XERS) Delayed: 8.43 --0 (-0%)
Previous Close $8.43    52 Week High
Open $8.43    52 Week Low
Day High $8.43    P/E N/A 
Day Low $8.43    EPS
Volume 3,417